603168.SH
Zhejiang Shapuaisi Pharmaceutical Co. Ltd.
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 5.54
−0.72%Margins
Gross margin
44.3%
EBITDA margin
-37.7%
EBIT margin
-59.6%
Net margin
-59.6%
FCF margin
-17.6%
-20.7%
Return on equity
-15.5%
Return on assets
-17.5%
Return on invested capital
0.25x
Asset turnover
CNY 26.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026